Last10K.com

Novavax Inc (NVAX) SEC Filing 8-K Material Event for the period ending Tuesday, July 11, 2023

Novavax Inc

HISTORY TOOLS
CIK: 723646 Ticker: NVAX

View differences made from one to another to evaluate Novavax Inc's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Novavax Inc.

Continue

Assess how Novavax Inc's management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Novavax Inc's Definitive Proxy Statement (Form DEF 14A) filed after their 2023 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

SEC Filing Tools

Financial Statements, Disclosures and Schedules

Inside this 8-K Corporate News

Cover
Ticker: NVAX
CIK: 1000694
Form Type: 8-K Corporate News
Accession Number: 0001104659-23-080024
Submitted to the SEC: Tue Jul 11 2023 5:12:43 PM EST
Accepted by the SEC: Tue Jul 11 2023
Period: Tuesday, July 11, 2023
Industry: Biological Products No Disgnostic Substances
Events:
  1. Event for Officers
  2. Financial Exhibit
  3. Vote of Security Holders

External Resources:
Stock Quote
Social Media
SEC.gov

Bookmark the Permalink:
https://last10k.com/sec-filings/nvax/0001104659-23-080024.htm